First Manhattan’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-885
| Closed | -$60.3K | – | 800 |
|
|
2024
Q1 | $60.3K | Buy |
885
+770
| +670% | +$52.5K | ﹤0.01% | 845 |
|
|
2023
Q4 | $7.2K | Sell |
115
-167
| -59% | -$10.5K | ﹤0.01% | 1159 |
|
|
2023
Q3 | $12.8K | Buy |
282
+232
| +464% | +$10.5K | ﹤0.01% | 1088 |
|
|
2023
Q2 | $2.81K | Hold |
50
| – | – | ﹤0.01% | 1279 |
|
|
2023
Q1 | $2.26K | Hold |
50
| – | – | ﹤0.01% | 1374 |
|
|
2022
Q4 | $2.03K | Hold |
50
| – | – | ﹤0.01% | 1533 |
|
|
2022
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 1376 |
|
|
2022
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 1399 |
|
|
2022
Q1 | $3K | Sell |
50
-634
| -93% | -$38K | ﹤0.01% | 1441 |
|
|
2021
Q4 | $51K | Sell |
684
-1,800
| -72% | -$134K | ﹤0.01% | 993 |
|
|
2021
Q3 | $278K | Buy |
2,484
+2,434
| +4,868% | +$272K | ﹤0.01% | 670 |
|
|
2021
Q2 | $8K | Hold |
50
| – | – | ﹤0.01% | 1308 |
|
|
2021
Q1 | $6K | Sell |
50
-300
| -86% | -$36K | ﹤0.01% | 1306 |
|
|
2020
Q4 | $53K | Buy |
350
+50
| +17% | +$7.57K | ﹤0.01% | 892 |
|
|
2020
Q3 | $25K | Hold |
300
| – | – | ﹤0.01% | 995 |
|
|
2020
Q2 | $22K | Hold |
300
| – | – | ﹤0.01% | 1015 |
|
|
2020
Q1 | $12K | Hold |
300
| – | – | ﹤0.01% | 1099 |
|
|
2019
Q4 | $18K | Hold |
300
| – | – | ﹤0.01% | 1058 |
|
|
2019
Q3 | $12K | Hold |
300
| – | – | ﹤0.01% | 1130 |
|
|
2019
Q2 | $14K | Hold |
300
| – | – | ﹤0.01% | 1142 |
|
|
2019
Q1 | $10K | Hold |
300
| – | – | ﹤0.01% | 1194 |
|
|
2018
Q4 | $8K | Hold |
300
| – | – | ﹤0.01% | 1190 |
|
|
2018
Q3 | $13K | Hold |
300
| – | – | ﹤0.01% | 1188 |
|
|
2018
Q2 | $17K | Buy |
+300
| New | +$17K | ﹤0.01% | 1121 |
|